Polyrizon Ltd. (PLRZ)

Chart not available yet

Data will show when the stock starts trading.

Market Cap	35.10M
Revenue (ttm)	n/a
Net Income (ttm)	-1.15M
Shares Out	5.66M
EPS (ttm)	-0.20
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	n/a
Previous Close	n/a
Day's Range	n/a
52-Week Range	n/a
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About PLRZ

Polyrizon is a development stage biotech company specializing in the development of innovative medical device hydrogels delivered in the form of nasal sprays, which form a thin hydrogel-based shield containment barrier in the nasal cavity that can provide a barrier against viruses and allergens from contacting the nasal epithelial tissue. Our proprietary Capture and Contain ™, or C&C, hydrogel technology, comprised of a mixture of naturally occurring building blocks, is delivered in the form of nasal sprays, and potentially functions as a “biol...

• Industry: Health Care
• Sector: Biotechnology
• Founded: 2005
• Employees: 3
• Stock Exchange: NASDAQ
• Ticker Symbol: PLRZ